Home
About
Warning Letter Wednesday
Work With Me
Testimonials
Appearances
Press
Regulatory Blog
Resources
More
Asa Waldstein
Community, Compliance, Natural Health
Marketing Strategy Compliance √
Minor label issues signal deeper compliance issues
6/11/25
Here are tips on using FDA’s ingredient directory
5/21/25
Ensure statements are not disparaging
4/30/25
Use FDA’s helpful resource (Criterion 2)
4/9/25
Curated testimonials are marketing claims
3/19/25
Disclosing material connection is essential for compliance
2/26/25
Small issues signify deeper noncompliance
2/5/25
Safety related product claims attract scrutiny
1/15/25
Dangerous products will be cited even if they do not contain disease claims
6/4/25
Extra attention is paid to animal CBD products
5/15/25
Use FDA's helpful resource (Criterion 7)
4/23/25
A look at the manufacturing and quality process
4/3/25
Distributors are responsible for the products they distribute
3/12/25
Take FDA inquiries seriously
2/19/25
Small words can drastically increase claim risk
1/29/25
Amazon compliance still needs improving
1/9/25
Use FDA’s helpful resource (criterion 6)
5/28/25
Learning from others' mistakes helps you be compliant
5/7/25
“Extra” claims are often non-compliant
4/16/25
Brands should monitor influencer posts for compliance
3/26/25
Following specifications prevents greater issues
3/5/25
Ensure ESG claims are substantiated
2/12/25
Ensure 483 responses are complete
1/22/25
Trustpilot reviews can be “marketing”
1/1/25